Does total lesion prostate-specific membrane antigen (PSMA) activity on (68)Ga-PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?

在局限性原发性前列腺癌患者中,(68)Ga-PSMA PET/CT 上的前列腺特异性膜抗原 (PSMA) 总病灶活性与 PSA 和前列腺切除术的组织病理学/临床结果是否相关?

阅读:2

Abstract

OBJECTIVES: To evaluate the relationship between total lesion PSMA (PSMA(TL)), serum PSA, histopathological findings and biochemical recurrence (BCR) in patients with localised prostate cancer (PCa). PATIENTS AND METHODS: This retrospective study assessed men undergoing (68)Ga-PSMA-11 PET/CT for newly diagnosed or treatment-naïve PCa localised to the prostate gland. Volumes of interest were manually mapped to derive SUV(max), SUV(mean), PSMA-avid tumour volume and PSMA(TL). PSMA(TL) was defined as the product of PSMA-avid primary tumour volume and SUV(mean). Spearman correlation tests evaluated associations between PET parameters and PSA, ISUP GG and radical prostatectomy (RP) histopathological outcomes. Associations between PET parameters and clinical outcomes were determined using Cox proportional hazards regression with results presented as HR and 95% CI. RESULTS: A total of 200 patients were included, with a median age of 68 (IQR 62-73) years, PSA of 9.5 (6.6-13.0) ng/ml and follow-up of 41 (25-60) months. Median PSMA(TL) was 29.6 (14.8-54.8) and SUV(max) 11.0 (6.8-17.9). PSMA(TL) and SUV(max) demonstrated a weak correlation with baseline PSA (ρ = 0.334, p < 0.001 and ρ = 0.343, p < 0.001), and PSMA(TL) showed a weak correlation with PSA density in the RP subgroup (ρ = 0.242, p = 0.021). Among 109 (54.5%) patients undergoing RP, PSMA(TL) and SUV(max) showed a weak correlation with ISUP GG (ρ = 0.233, p = 0.015 and ρ = 0.340, p < 0.001). There was a weak correlation between PSMA(TL) and primary tumour stage (ρ = 0.244, p = 0.010) and lymph node stage (ρ = 0.259, p = 0.007). PSMA(TL) was significantly higher in those with seminal vesicle involvement (p = 0.011), perineural invasion (p = 0.025) and lymphovascular invasion (p = 0.002). BCR occurred in 46 patients (42%), with a 1% increased risk of BCR per unit increase in PSMA(TL) (HR 1.01, 95% CI 1.00-1.02, p = 0.011). CONCLUSIONS: PSMA(TL) correlates with PSA, PSA density, ISUP GG, RP histopathological findings and BCR. As an adjunct to SUV(max), PSMA(TL) has the potential to be a useful prognostic tool. Further research is needed to assess its clinical utility.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。